Table 1.
Baseline characteristics
| STEMI N = 4899 | NSTEMI N = 5159 | |||||
|---|---|---|---|---|---|---|
| Women n = 1214 | Men n = 3685 | p-value | Women n = 1776 | Men n = 3383 | p-value | |
| Age, yearsa | 71 (60–80) | 61 (53–70) | <0.0001 | 77 (65–85) | 67 (57–77) | <0.0001 |
| Smoker/ex-smoker, n (%)b | 642 (62.0) | 2344 (69.8) | <0.0001 | 731 (51.0) | 1949 (66.1) | <0.0001 |
| Diabetes mellitus, n (%)b | 163 (13.4) | 465 (12.6) | 0.469 | 323 (18.2) | 659 (19.5) | 0.246 |
| Previous hyperlipidemia, n (%)b,c | 148 (12.2) | 421 (11.5) | 0.468 | 207 (11.7) | 461 (13.7) | 0.041 |
| Previous hypertension, n (%)b | 521 (42.9) | 1163 (31.6) | <0.0001 | 892 (50.2) | 1320 (39.0) | <0.0001 |
| Previous MI, n (%)b | 145 (11.9) | 492 (13.4) | 0.198 | 439 (24.7) | 956 (28.3) | 0.006 |
| Previous PCI or CABG, n (%)b | 87 (7.2) | 428 (11.6) | <0.0001 | 267 (15.0) | 838 (24.8) | <0.0001 |
| Previous stroke, n (%)b | 95 (7.8) | 183 (5.0) | 0.0002 | 231 (13.0) | 341 (10.1) | 0.002 |
| Family history, n (%)b,d | 160 (13.3) | 606 (16.4) | 0.007 | 158 (8.9) | 438 (13.0) | <0.0001 |
| Peripheral artery disease, n (%)b | 60 (4.9) | 143 (3.9) | 0.112 | 121 (6.8) | 258 (7.6) | 0.276 |
MI Myocardial infarction, PCI Percutaneous coronary intervention, CABG Coronary artery bypass grafting
a median (25th-75th percentile)
b (%) = percent of patients with available information, denominator may vary
c Hyperlipidemia defined as treatment with lipid-lowering drugs at time of admission
d Coronary artery disease before age 65 years in women, 55 years in men in 1st order relatives